Skip to main content

Table 1

From: One-year observation of leflunomide effectiveness and saftey in juvenile idiopathic arthritis : a clinical practice review (preliminary data)

*median baseline 3 M 12 M
SJC 2.54 0.64 0
TJC 2.61 1.07 0.07
LRMC 2.14 1.57 0.92